Equity alert: rosen, a leading law firm, encourages immunitybio, inc. investors with losses to secure counsel before important deadline in securities class action – ibrx

New york--(business wire)--why: rosen law firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of immunitybio, inc. (nasdaq: ibrx) between may 23, 2022 and may 10, 2023, both dates inclusive (the “class period”). a class action lawsuit has already been filed. if you wish to serve as lead plaintiff, you must move the court no later than august 29, 2023. so what: if you purchased immunitybio securities during the class perio.
IBRX Ratings Summary
IBRX Quant Ranking